The store will not work correctly when cookies are disabled.
1-((8-(4-tert-butylphenyl)-1,5-naphthyridin-4-yl)methyl)guanidine
ID: ALA2413358
PubChem CID: 71817835
Max Phase: Preclinical
Molecular Formula: C20H23N5
Molecular Weight: 333.44
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)c1ccc(-c2ccnc3c(CNC(=N)N)ccnc23)cc1
Standard InChI: InChI=1S/C20H23N5/c1-20(2,3)15-6-4-13(5-7-15)16-9-11-23-17-14(12-25-19(21)22)8-10-24-18(16)17/h4-11H,12H2,1-3H3,(H4,21,22,25)
Standard InChI Key: BQAPBOBYFZVYEJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
26.4895 -14.5454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4884 -15.3728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2032 -15.7856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2014 -14.1327 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.9167 -14.5418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9175 -15.3686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6328 -15.7796 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.3478 -15.3648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3431 -14.5348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6271 -14.1277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6223 -13.3078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3361 -12.8921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3321 -12.0679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6149 -11.6583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9004 -12.0791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9079 -12.9019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2051 -16.6106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4916 -17.0247 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.6095 -10.8335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3212 -10.4162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8923 -10.4257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6034 -10.0081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4935 -17.8497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7801 -18.2639 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.2089 -18.2606 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
10 11 1 0
3 17 1 0
17 18 1 0
14 19 1 0
19 20 1 0
19 21 1 0
19 22 1 0
18 23 1 0
23 24 2 0
23 25 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 333.44 | Molecular Weight (Monoisotopic): 333.1953 | AlogP: 3.58 | #Rotatable Bonds: 3 |
Polar Surface Area: 87.68 | Molecular Species: BASE | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 11.96 | CX LogP: 3.28 | CX LogD: 0.87 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.50 | Np Likeness Score: -0.57 |
References
1. Parhi AK, Zhang Y, Saionz KW, Pradhan P, Kaul M, Trivedi K, Pilch DS, LaVoie EJ.. (2013) Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines., 23 (17): [PMID:23891185] [10.1016/j.bmcl.2013.06.048] |